GRC Report Staff

The European Commission has stepped in with a timely adjustment to ease pressure on companies already navigating the EU’s sustainability reporting rules. On July 11, the Commission adopted a “quick fix” to the first set of European Sustainability Reporting Standards (ESRS), giving a break to companies that began reporting for financial year 2024, commonly referred to as “wave one” reporters. These companies will now be able to skip certain additional disclosures for two more years, covering financial years 2025 and 2026.

The EU wants to make life a little easier for smaller businesses under the GDPR, but Europe's top data protection authorities are asking a few questions before they sign off.

The California Air Resources Board (CARB) has published a detailed FAQ to guide companies preparing for two new climate disclosure laws: the Climate Corporate Data Accountability Act (Health and Safety Code section 38532) and the Climate-Related Financial Risk Disclosure Program (section 38533). The document outlines early steps for compliance, reporting timelines, and public engagement opportunities, ahead of formal regulations expected later this year.

After more than two decades of steady service, the EU’s core antitrust enforcement framework is due for a refresh, and this time, the European Commission isn’t going it alone. It wants feedback from businesses, legal experts, competition authorities, and anyone else who has a stake in how the EU tackles anti-competitive behavior in an increasingly digital economy.

TikTok is once again in the crosshairs of Ireland’s privacy watchdog after it admitted to storing some European user data on servers in China, contradicting what it had previously told regulators.

The European Banking Authority (EBA) has recently announced that it is launching a public consultation to revise its long-standing Guidelines on Product Oversight and Governance (POG). The revisions would, for the first time, formally incorporate ESG-related risks into how financial products are designed, marketed, and reviewed without, the EBA insists, adding unnecessary red tape.

A federal judge has ordered CVS Health to pay nearly $950 million in penalties and damages after its Omnicare unit was found to have illegally billed government healthcare programs for prescription drugs that weren’t properly authorized. The massive award stems from a whistleblower case that uncovered years of fraudulent dispensing practices tied to more than 3.3 million false claims.